Labeler
Boehringer Ingelheim Pharmaceuticals, Inc. NDC Codes
Boehringer Ingelheim Pharmaceuticals, Inc. lists 65 finished drug products in the FDA NDC Directory under NDC labeler code 0597.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Pradaxa, Cyltezo, Adalimumab-adbm, Trijardy XR, Synjardy XR, Synjardy, Spevigo, Gilotrif, Jentadueto, Micardis HCT, Jascayd, Jentadueto XR, Spiriva Respimat, Glyxambi, Ofev
- Active ingredients
- Metformin hydrochloride, Empagliflozin, Linagliptin, Dabigatran etexilate mesylate, Spesolimab, Afatinib, Telmisartan, Hydrochlorothiazide, Nerandomilast, Tiotropium bromide anhydrous, Tiotropium bromide monohydrate, Olodaterol hydrochloride
- NDC labeler codes
- 0597
- Strengths
- Metformin hydrochloride 1000 mg/1; Linagliptin 5 mg/1; Linagliptin 2.5 mg/1; Empagliflozin 10 mg/1; Empagliflozin 12.5 mg/1; Empagliflozin 25 mg/1; Empagliflozin 5 mg/1; Metformin hydrochloride 500 mg/1; Dabigatran etexilate mesylate 110 mg/1; Dabigatran etexilate mesylate 150 mg/1; Hydrochlorothiazide 12.5 mg/1; Telmisartan 80 mg/1; Nerandomilast 9 mg/1; Nerandomilast 18 mg/1; Zongertinib 60 mg/1; Spesolimab 300 mg/1; Spesolimab 150 mg/1; Spesolimab 60 mg/mL; Dabigatran etexilate mesylate 50 mg/1; Dabigatran etexilate mesylate 20 mg/1
- Dosage forms
- Tablet, Film coated, Kit, Tablet, Extended release, Tablet, Pellet, Capsule, Spray, Metered, Injection, Tablet, Film coated, Extended release, Aerosol, Metered
- Routes
- Oral, Respiratory (Inhalation), Intravenous
- Drug classes (FDA established)
- Biguanide, Sodium-Glucose Cotransporter 2 Inhibitor, Dipeptidyl Peptidase 4 Inhibitor, Direct Thrombin Inhibitor, Kinase Inhibitor, Anticholinergic, Interleukin-36 Receptor Antagonist, beta2-Adrenergic Agonist, Angiotensin 2 Receptor Blocker, Thiazide Diuretic, Humanized Monoclonal Antibody Fragment
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 111
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Jascaydnerandomilast | Nerandomilast 9 mg/1 | Tablet, Film coatedOral | 0597-2465 | 00597-2465-41 | — |
| Jascaydnerandomilast | Nerandomilast 18 mg/1 | Tablet, Film coatedOral | 0597-7313 | 00597-7313-21 | — |
| Hernexeoszongertinib | Zongertinib 60 mg/1 | Tablet, Film coatedOral | 0597-9257 | 00597-9257-5900597-9257-86 | — |
| Spevigospesolimab-sbzo | Spesolimab 300 mg/1 | InjectionIntravenous | 0597-7705 | 00597-7705-4100597-7705-72 | — |
| Cyltezoadalimumab-adbm | — | Kit | 0597-0485 | 00597-0485-20 | — |
| Adalimumab-adbm | — | Kit | 0597-0565 | 00597-0565-20 | — |
| Adalimumab-adbm | — | Kit | 0597-0575 | 00597-0575-50 | — |
| Cyltezoadalimumab-adbm | — | Kit | 0597-0495 | 00597-0495-50 | — |
| Spevigospesolimab-sbzo | Spesolimab 150 mg/1 | InjectionIntravenous | 0597-0620 | 00597-0620-20 | — |
| Adalimumab-adbm | — | Kit | 0597-0545 | 00597-0545-22 | — |
| Adalimumab-adbm | — | Kit | 0597-0555 | 00597-0555-80 | — |
| Adalimumab-adbm | — | Kit | 0597-0585 | 00597-0585-89 | — |
| Adalimumab-adbm | — | Kit | 0597-0595 | 00597-0595-20 | — |
| Cyltezoadalimumab-adbm | — | Kit | 0597-0370 | 00597-0370-82 | — |
| Cyltezoadalimumab-adbm | — | Kit | 0597-0375 | 00597-0375-97 | — |
| Cyltezoadalimumab-adbm | — | Kit | 0597-0400 | 00597-0400-89 | — |
| Cyltezoadalimumab-adbm | — | Kit | 0597-0405 | 00597-0405-80 | — |
| Spevigospesolimab-sbzo | Spesolimab 60 mg/mL | InjectionIntravenous | 0597-0035 | 00597-0035-10 | — |
| Pradaxadabigatran etexilate | Dabigatran etexilate mesylate 50 mg/1 | PelletOral | 0597-0440 | 00597-0440-53 | — |
| Pradaxadabigatran etexilate | Dabigatran etexilate mesylate 110 mg/1 | PelletOral | 0597-0445 | 00597-0445-87 | — |
| Pradaxadabigatran etexilate | Dabigatran etexilate mesylate 150 mg/1 | PelletOral | 0597-0450 | 00597-0450-16 | — |
| Pradaxadabigatran etexilate | Dabigatran etexilate mesylate 20 mg/1 | PelletOral | 0597-0425 | 00597-0425-78 | — |
| Pradaxadabigatran etexilate | Dabigatran etexilate mesylate 30 mg/1 | PelletOral | 0597-0430 | 00597-0430-18 | — |
| Pradaxadabigatran etexilate | Dabigatran etexilate mesylate 40 mg/1 | PelletOral | 0597-0435 | 00597-0435-96 | — |
| Trijardy XRempagliflozin, linagliptin, metformin hydrochloride | Empagliflozin 10 mg/1 + 2 more ingredients | Tablet, Extended releaseOral | 0597-0380 | 00597-0380-1300597-0380-68 | — |
| Trijardy XRempagliflozin, linagliptin, metformin hydrochloride | Empagliflozin 12.5 mg/1 + 2 more ingredients | Tablet, Extended releaseOral | 0597-0385 | 00597-0385-7700597-0385-86 | — |
| Trijardy XRempagliflozin, linagliptin, metformin hydrochloride | Empagliflozin 25 mg/1 + 2 more ingredients | Tablet, Extended releaseOral | 0597-0390 | 00597-0390-1300597-0390-71 | — |
| Trijardy XRempagliflozin, linagliptin, metformin hydrochloride | Empagliflozin 5 mg/1 + 2 more ingredients | Tablet, Extended releaseOral | 0597-0395 | 00597-0395-2300597-0395-82 | — |
| Pradaxadabigatran etexilate mesylate | Dabigatran etexilate mesylate 150 mg/1 | CapsuleOral | 0597-0360 | 00597-0360-5500597-0360-82 | — |
| Synjardy XRempagliflozin, metformin hydrochloride | Empagliflozin 10 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Extended releaseOral | 0597-0280 | 00597-0280-7300597-0280-90 | — |
| Synjardy XRempagliflozin, metformin hydrochloride | Empagliflozin 5 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Extended releaseOral | 0597-0290 | 00597-0290-5900597-0290-74 | — |
| Synjardy XRempagliflozin, metformin hydrochloride | Empagliflozin 25 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Extended releaseOral | 0597-0295 | 00597-0295-6100597-0295-7800597-0295-88 | — |
| Synjardy XRempagliflozin, metformin hydrochloride | Empagliflozin 12.5 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Extended releaseOral | 0597-0300 | 00597-0300-2000597-0300-4500597-0300-93 | — |
| Jentadueto XRlinagliptin and metformin hydrochloride | Linagliptin 5 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | 0597-0275 | 00597-0275-3300597-0275-81 | — |
| Jentadueto XRlinagliptin and metformin hydrochloride | Linagliptin 2.5 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | 0597-0270 | 00597-0270-7300597-0270-94 | — |
| Pradaxadabigatran etexilate mesylate | Dabigatran etexilate mesylate 110 mg/1 | CapsuleOral | 0597-0108 | 00597-0108-5400597-0108-60 | — |
| Praxbindidarucizumab | Idarucizumab 50 mg/mL | InjectionIntravenous | 0597-0197 | 00597-0197-05 | — |
| Spiriva Respimattiotropium bromide inhalation spray | Tiotropium bromide anhydrous 1.562 ug/1 | Spray, MeteredRespiratory (Inhalation) | 0597-0160 | 00597-0160-2800597-0160-61 | — |
| Synjardyempagliflozin and metformin hydrochloride | Empagliflozin 12.5 mg/1; Metformin hydrochloride 500 mg/1 | TabletOral | 0597-0180 | 00597-0180-1800597-0180-60 | — |
| Synjardyempagliflozin and metformin hydrochloride | Empagliflozin 5 mg/1; Metformin hydrochloride 500 mg/1 | TabletOral | 0597-0159 | 00597-0159-1800597-0159-60 | — |
| Synjardyempagliflozin and metformin hydrochloride | Empagliflozin 12.5 mg/1; Metformin hydrochloride 1000 mg/1 | TabletOral | 0597-0168 | 00597-0168-1800597-0168-6000597-0168-66 | — |
| Synjardyempagliflozin and metformin hydrochloride | Empagliflozin 5 mg/1; Metformin hydrochloride 1000 mg/1 | TabletOral | 0597-0175 | 00597-0175-1800597-0175-60 | — |
| Stiolto Respimattiotropium bromide and olodaterol | Tiotropium bromide monohydrate 3.124 ug/1; Olodaterol hydrochloride 2.736 ug/1 | Spray, MeteredRespiratory (Inhalation) | 0597-0155 | 00597-0155-2800597-0155-6100597-0155-70 | — |
| Glyxambiempagliflozin and linagliptin | Empagliflozin 10 mg/1; Linagliptin 5 mg/1 | Tablet, Film coatedOral | 0597-0182 | 00597-0182-3000597-0182-3900597-0182-90 | — |
| Glyxambiempagliflozin and linagliptin | Empagliflozin 25 mg/1; Linagliptin 5 mg/1 | Tablet, Film coatedOral | 0597-0164 | 00597-0164-3000597-0164-3900597-0164-90 | — |
| Ofevnintedanib | Nintedanib esylate 100 mg/1 | CapsuleOral | 0597-0143 | 00597-0143-60 | — |
| Ofevnintedanib | Nintedanib esylate 150 mg/1 | CapsuleOral | 0597-0145 | 00597-0145-60 | — |
| Spiriva Respimattiotropium bromide inhalation spray | Tiotropium bromide anhydrous 3.124 ug/1 | Spray, MeteredRespiratory (Inhalation) | 0597-0100 | 00597-0100-2800597-0100-5100597-0100-61 | — |
| Striverdi Respimatolodaterol respimat inhalation spray | Olodaterol hydrochloride 2.5 ug/1 | Spray, MeteredRespiratory (Inhalation) | 0597-0192 | 00597-0192-61 | — |
| Jardianceempagliflozin | Empagliflozin 10 mg/1 | Tablet, Film coatedOral | 0597-0152 | 00597-0152-0700597-0152-3000597-0152-37+1 more | — |
Boehringer Ingelheim Pharmaceuticals, Inc.: common questions
- What is Boehringer Ingelheim Pharmaceuticals, Inc.'s NDC labeler code?
- 0597. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Boehringer Ingelheim Pharmaceuticals, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.